Brief Answer:
explained

Detailed Answer:
Hello and Welcome

I appreciate your concern.


Pathological or Degenerative Myopia is quite different from the simple refractive myopia or nearsightedness that affects so many people around the world. Pathological myopia is an extremely high amount of nearsightedness that causes a major alteration of the shape or globe of the eye, which may lead to profound vision loss.

In Myopic Macular Degeneration As the eyeball grows and stretches, it may also cause an area of atrophy and/or cracks in the layers under the retina. These cracks can serve as conduits for abnormal blood vessels to grow under the retina. These vessels can hemorrhage and scar which is similar to what happens in wet macular degeneration. The onset of the nets of abnormal blood vessels, called Fuch’s spots, often occur in the 4th to 6th decades of life. Approximately 5% of pathological myopia patients develop Fuch’s spots, which lead to damage in the macular region of the eye and a subsequent loss of central vision

To summarize the course of this condition: It presents for the majority of people, as an inherited genetic condition. This is why the incidence of this condition varies so much between the various ethnic groups. The genetic defects responsible may be transmitted between the generations in a variety of ways, and may produce very different degrees of myopia in different family members

In the U.S.A. two prominent groups advocated scleral reinforcement for degenerative myopia. Dr XXXXXXX Curtin lead the effort in New York, while a California-based group of surgeons used rather different procedures. The “West Coast” approach evolved from pioneering work by Borley and Snyder at the Stanford medical campus in San Francisco. Curtin tried different approaches before finally concluding that these had been ineffective, and noting some significant complications in some of their cases. Meanwhile, on the West Coast, Snyder, XXXXXXX and Miller continued to develop their surgical approaches to scleral reinforcement, with no reports of adverse safety issues. These surgeons had a firm conviction that they were stabilizing axial myopia progression through their efforts

The appropriateness of buckling surgery for high axial myopia should be considered on a case-by-case basis.

Degenerative myopia may be preventable in the future. Today, however, the usual treatments are limited to optical correction, intra-ocular pressure control, and attention to complications that may occur. The use of scleral buckling can prevent axial extension and minimize the toll of myopic macular degeneration on future visual function. At-risk eyes deserve careful evaluation and follow-up, with early treatment where appropriate. New buckling materials are being evaluated for their use in the more severe cases in all age groups. These are eyes in which greater areas of support and stronger buckling forces may be helpful. As always, the safety of any treatment needs to be evaluated in terms of its risk-to-benefit ratio.

Correlation between high intake of lutein , anti oxidants and lower incidence of macular degeneration and cataracts has been found. so no harm in taking it.





Let me know if you have any query

wishing you best of health

Thanks

---